Industries
Pharma & Healthcare
Strategic advisory for pharmaceutical companies, healthcare providers, and medical device manufacturers navigating complex regulatory and market access challenges.
Our Expertise
Healthcare and life sciences present unique strategic challenges. Regulatory complexity, long development cycles, and evolving reimbursement landscapes require advisors who truly understand the sector.
We bring deep expertise in pharmaceutical commercialization, market access strategy, and healthcare provider operations. Our team understands both the science and the business of healthcare.
We work with global pharma companies, regional healthcare providers, and investors seeking opportunities in this complex but rewarding sector.
Segments We Serve
Pharmaceutical
Originator pharma, generics, and specialty pharmaceuticals
Healthcare Providers
Hospitals, clinics, and healthcare service organizations
Medical Devices
Medical technology and diagnostic equipment manufacturers
Life Sciences
Biotech, CROs, and life science tools and services
Digital Health
Health tech, telemedicine, and digital therapeutics
How We Help
We support pharma, healthcare, and life sciences clients across strategic and commercial challenges.
Commercial Strategy
Define commercial priorities and go-to-market approaches for pharmaceutical and healthcare products and services.
Market Access & Pricing
Navigate complex reimbursement landscapes and develop pricing strategies that balance access with value capture.
Regulatory Strategy
Turn regulatory requirements into competitive advantage through strategic planning and efficient compliance.
Commercial Due Diligence
Rigorous assessment of pharma, biotech, and healthcare targets for PE investors and strategic acquirers.
Portfolio Optimization
Evaluate and prioritize product portfolios to maximize value across therapeutic areas and geographies.
Go-to-Market Planning
Develop comprehensive launch plans and market entry strategies for new products and services.
Industry Trends
Healthcare and life sciences face fundamental shifts in care delivery, reimbursement, and technology. Understanding these dynamics shapes how we approach strategic challenges in the sector.
Value-Based Healthcare
Payers increasingly demand evidence of real-world outcomes. This shifts commercial strategies toward value demonstration and outcomes-based contracting.
Digital Health Integration
Digital therapeutics, remote monitoring, and AI-driven diagnostics create new care models and reshape traditional product boundaries.
Specialty Focus
Pipeline focus on specialty and rare diseases drives need for targeted commercial models and specialized market access capabilities.
Healthcare System Pressures
Cost containment, workforce shortages, and access challenges drive healthcare system restructuring and new care delivery models.
Our Healthcare Perspective
Pharma and healthcare is a core focus area for Eichland. Our team brings direct experience from pharmaceutical companies, healthcare providers, and life sciences consulting. We understand the sector's unique dynamics—long development cycles, complex regulatory requirements, evolving reimbursement landscapes, and the critical importance of scientific credibility.
We work with global pharmaceutical companies optimizing their commercial strategies, healthcare providers navigating system transformation, and PE investors evaluating opportunities across the healthcare value chain. Our Nordic perspective provides particular insight into Scandinavian healthcare systems, known for their quality, efficiency, and innovation.
Work with us in Pharma & Healthcare
Let's discuss how we can support your strategic objectives.